<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>BiG生物创新社 | wechat-feeds</title><link>http://MzkxNTA5NjM1OA.favicon.privacyhide.com/favicon.ico</link><description>BiG, Biologics Innovation Group. To nurture an Eco-system for Biologics innovation and imprint China on Global map.</description><managingEditor> (hellodword)</managingEditor><pubDate>Wed, 28 Apr 2021 19:23:09 +0800</pubDate><image><url>http://MzkxNTA5NjM1OA.favicon.privacyhide.com/favicon.ico</url><title>BiG生物创新社 | wechat-feeds</title><link>http://MzkxNTA5NjM1OA.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>工程化红细胞：细胞疗法的下一个春天？</title><link>https://mp.weixin.qq.com/s/ALqPJ1MaHp3RB8aGPDeulQ</link><description></description><content:encoded><![CDATA[工程化红细胞：细胞疗法的下一个春天？]]></content:encoded><pubDate>Wed, 28 Apr 2021 17:55:30 +0800</pubDate></item><item><title>集赞五一 脚踏祥云｜BiG携50+医药大咖喊你参会！</title><link>https://mp.weixin.qq.com/s/hsiAKMnmt3S75svl_FC9_w</link><description></description><content:encoded><![CDATA[集赞五一 脚踏祥云｜BiG携50+医药大咖喊你参会！]]></content:encoded><pubDate>Tue, 27 Apr 2021 15:45:12 +0800</pubDate></item><item><title>新江湖｜美迪西加入BiG会员机构！</title><link>https://mp.weixin.qq.com/s/1M8eASOYpsV0qGL1JN5whA</link><description></description><content:encoded><![CDATA[新江湖｜美迪西加入BiG会员机构！]]></content:encoded><pubDate>Tue, 27 Apr 2021 15:45:12 +0800</pubDate></item><item><title>免疫治疗精准筛选利器！分子免疫PET影像技术</title><link>https://mp.weixin.qq.com/s/M8CVUROrGbJriQ35H5GKZQ</link><description></description><content:encoded><![CDATA[免疫治疗精准筛选利器！分子免疫PET影像技术]]></content:encoded><pubDate>Mon, 26 Apr 2021 14:16:21 +0800</pubDate></item><item><title>新江湖｜夏振勤、胡邵京、刘骏、刘维加入BiG！</title><link>https://mp.weixin.qq.com/s/7VLxcnelynqW2P9-UrBLRA</link><description></description><content:encoded><![CDATA[新江湖｜夏振勤、胡邵京、刘骏、刘维加入BiG！]]></content:encoded><pubDate>Mon, 26 Apr 2021 14:16:21 +0800</pubDate></item><item><title>mRNA药物时代，疫苗 and Beyond！</title><link>https://mp.weixin.qq.com/s/IobCmOj6aRNOx2rJ55g40A</link><description></description><content:encoded><![CDATA[mRNA药物时代，疫苗 and Beyond！]]></content:encoded><pubDate>Sun, 25 Apr 2021 14:39:34 +0800</pubDate></item><item><title>荐*PCPI论坛 | 日程更新！临床专家私享会进入倒计时</title><link>https://mp.weixin.qq.com/s/2y7MTUyuLGnbaGloyeJduw</link><description></description><content:encoded><![CDATA[荐*PCPI论坛 | 日程更新！临床专家私享会进入倒计时]]></content:encoded><pubDate>Sun, 25 Apr 2021 14:39:34 +0800</pubDate></item><item><title>自免明星靶点IL-17：从发现到靶向治疗</title><link>https://mp.weixin.qq.com/s/uXkLKQVZPWhj0h7TUkG1BA</link><description></description><content:encoded><![CDATA[自免明星靶点IL-17：从发现到靶向治疗]]></content:encoded><pubDate>Fri, 23 Apr 2021 17:44:43 +0800</pubDate></item><item><title>新江湖｜苏州柏觅医药加入BiG会员机构！</title><link>https://mp.weixin.qq.com/s/wN4NRP0pq5E6UD4x5aktzw</link><description></description><content:encoded><![CDATA[新江湖｜苏州柏觅医药加入BiG会员机构！]]></content:encoded><pubDate>Fri, 23 Apr 2021 17:44:43 +0800</pubDate></item><item><title>中国Biotech是否一定要成为MNC｜BiG神仙辩论</title><link>https://mp.weixin.qq.com/s/Tq3suU68LOKL-0RFWRodMw</link><description></description><content:encoded><![CDATA[中国Biotech是否一定要成为MNC｜BiG神仙辩论]]></content:encoded><pubDate>Wed, 21 Apr 2021 18:06:55 +0800</pubDate></item><item><title>信达1+2选择性CD47/PD-L1双抗｜BiG七周年</title><link>https://mp.weixin.qq.com/s/FzvvIeAwHJcvVnVgrGe1zw</link><description></description><content:encoded><![CDATA[信达1+2选择性CD47/PD-L1双抗｜BiG七周年]]></content:encoded><pubDate>Wed, 21 Apr 2021 18:06:55 +0800</pubDate></item><item><title>轻重链错配？双特异抗体技术平台中的Linker策略</title><link>https://mp.weixin.qq.com/s/qes8ssug4ttGWtxrDX3pGw</link><description></description><content:encoded><![CDATA[轻重链错配？双特异抗体技术平台中的Linker策略]]></content:encoded><pubDate>Tue, 20 Apr 2021 20:14:54 +0800</pubDate></item><item><title>议程首发｜首届中国生物计算大会举办在即，李彦宏邀数位院士专家共议行业未来！</title><link>https://mp.weixin.qq.com/s/fRx9uNdsF9L0k69Xat850Q</link><description></description><content:encoded><![CDATA[议程首发｜首届中国生物计算大会举办在即，李彦宏邀数位院士专家共议行业未来！]]></content:encoded><pubDate>Tue, 20 Apr 2021 20:14:54 +0800</pubDate></item><item><title>类风湿关节炎：生物药热潮渐退，JAK机会来了？</title><link>https://mp.weixin.qq.com/s/I0XBAuGgvNeo0gL7egctjA</link><description></description><content:encoded><![CDATA[类风湿关节炎：生物药热潮渐退，JAK机会来了？]]></content:encoded><pubDate>Sun, 18 Apr 2021 10:03:18 +0800</pubDate></item><item><title>创新蓝海，百药争鸣｜BiG七周年半壁江山阵容揭秘</title><link>https://mp.weixin.qq.com/s/jz_r9zlH-vDkivnmn1mIWA</link><description></description><content:encoded><![CDATA[创新蓝海，百药争鸣｜BiG七周年半壁江山阵容揭秘]]></content:encoded><pubDate>Fri, 16 Apr 2021 16:43:45 +0800</pubDate></item><item><title>新江湖｜凌腾医药加入BiG会员机构！</title><link>https://mp.weixin.qq.com/s/o-qVmqn_fv7LAhjRZPVrRw</link><description></description><content:encoded><![CDATA[新江湖｜凌腾医药加入BiG会员机构！]]></content:encoded><pubDate>Fri, 16 Apr 2021 16:43:45 +0800</pubDate></item><item><title>肠道微生物，后PD-1免疫时代的另辟蹊径</title><link>https://mp.weixin.qq.com/s/fT__xjpBOPNZ7QsqUGbBZQ</link><description></description><content:encoded><![CDATA[肠道微生物，后PD-1免疫时代的另辟蹊径]]></content:encoded><pubDate>Thu, 15 Apr 2021 15:36:10 +0800</pubDate></item><item><title>春天的故事丨春天Proswell总裁兼创始人宋青春受邀《Pharma Tech Outlook》专访</title><link>https://mp.weixin.qq.com/s/2IOO7ANYE64H-nNTbwAxlQ</link><description></description><content:encoded><![CDATA[春天的故事丨春天Proswell总裁兼创始人宋青春受邀《Pharma Tech Outlook》专访]]></content:encoded><pubDate>Thu, 15 Apr 2021 15:36:10 +0800</pubDate></item><item><title>抗体前沿碰撞RNA疗法｜BiG春季聚会*苏州站</title><link>https://mp.weixin.qq.com/s/AC3VrzKgCby6OAeJhfPFMA</link><description></description><content:encoded><![CDATA[抗体前沿碰撞RNA疗法｜BiG春季聚会*苏州站]]></content:encoded><pubDate>Thu, 15 Apr 2021 15:36:10 +0800</pubDate></item></channel></rss>